Cur is one of the greatest opportunities I have ever had the pleasure of investing in. The upside of this stock is unbelievable. It will be impossible to keep the good results of the ALS phase II a secret until it is completed. The way things are now, with tweeter, blogs and facebook they will be hard pressed to keep happy patients from spreading the word. Within two months and maybe sooner based on Ted Harada's results in Phase I we should know what is going on. The market for this treatment is not limited to ALS. It includes almost any neural problem that affects the spinal cord, Multiple Sclerosis, Parkinsons, and many others.
Then there is the small molecule drug for a myriad of brain disorders. If this shows efficacy the ceiling is raised even higher. Much higher! This is a pill taken to enlarge their brain to treat depression, Alzheimers, brain injury, and possibly just to get smarter. Who knows at this time. Garr said it not a matter if this drug will grow the neural cells but how much it will grow. That is what will be proven with the trial. This is serious medicine they dealing with and could be game changing for many patients throughout the world.
I do think we should a good idea just exactly how good everything is before the end of the year. For me I have been buying what I can for several years. Good luck to all investors and patients
Gaileo
Market Data 
Markets 
AI
